Indication

Occipital Horn Syndrome

1 clinical trial

1 product

Clinical trial

Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Adults With Occipital Horn Syndrome: Double-blind Placebo-controlled Randomized Crossover Clinical Trial

Status: Recruiting, Estimated PCD: 2025-06-30

Product